Effective dose range of candesartan cilexetil for systemic hypertension

被引:19
|
作者
Bell, TP
DeQuattro, V
Lasseter, KC
Ruff, D
Hardison, JD
Cushing, D
Kezer, AE
Michelson, EL
机构
[1] Univ S Alabama, Med Ctr, Mobile, AL USA
[2] Univ So Calif, Sch Med, Los Angeles, CA USA
[3] Clin Pharmacol Associates, Miami, FL USA
[4] Healthcare Discoveries, San Antonio, TX USA
[5] Astra Pharmaceut LP, Wayne, PA USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1999年 / 83卷 / 02期
关键词
D O I
10.1016/S0002-9149(98)00837-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The results of this randomized, double-blind, placebo-controlled, forced-dose titration study in a diverse population of hypertensive patients in the US indicate that candesartan cilexetil has clinically meaningful dose-related blood pressure-lowering effects and that maximum blood pressure reduction is achieved with doses of 16 and 32 mg given once daily. This study confirms that candesartan cilexetil is a highly effective antihypertensive agent with an excellent tolerability and safety profile, without dose-related adverse effects.
引用
收藏
页码:272 / +
页数:5
相关论文
共 50 条
  • [21] Comparison of angiotensin II receptor blockers: Impact of missed doses of candesartan cilexetil and losartan in systemic hypertension
    Mancia, G
    Dell'Oro, R
    Turri, C
    Grassi, G
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (10A): : 28S - 34S
  • [22] Spotlight on the pharmacoeconomics of candesartan cilexetil in chronic heart failure and hypertension
    Plosker, Greg L.
    Keam, Susan J.
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2007, 15 (01) : 57 - 63
  • [23] Effects of candesartan cilexetil on microcirculation in patients with previously untreated hypertension
    Kobalava, ZD
    Sklizkova, LA
    Kozlov, VI
    Moiseev, VS
    JOURNAL OF HYPERTENSION, 2000, 18 : S189 - S189
  • [24] Comparative study on Candesartan cilexetil and Nevibolol in arterial hypertension control
    Mountzouris, D
    JOURNAL OF HYPERTENSION, 2003, 21 : S330 - S330
  • [25] Candesartan cilexetil: an update
    Joost, Alexander
    Schunkert, Heribert
    Radke, Peter Walter
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (11) : 1769 - 1780
  • [26] Single and multiple dose pharmacokinetics of candesartan cilexetil in healthy volunteers
    Riddell, JG
    Högemann, AM
    JOURNAL OF HYPERTENSION, 1998, 16 : S243 - S243
  • [27] Preserving target-organ function with candesartan cilexetil in patients with hypertension
    Zannad, F
    BLOOD PRESSURE, 2000, 9 : 36 - 39
  • [28] Formulation and evaluation of rapid disintegrating tablet of candesartan cilexetil for the management of hypertension
    Kumar, Lokesh
    Meel, Rakesh Kumar
    Godara, Ashu
    Singh, Virendra
    Agarwal, Anil
    Journal of Chemical and Pharmaceutical Research, 2014, 6 (08) : 421 - 428
  • [29] Candesartan Cilexetil plus Hydrochlorothiazide CombinationA Review of its Use in Hypertension
    Ezequiel Balmori Melian
    Blair Jarvis
    Drugs, 2002, 62 : 787 - 816
  • [30] The CASH study: Candesartan cilexetil in isolated systolic hypertension baseline data
    Nisse-Durgeat, S
    Revel, F
    Ollivier, JP
    JOURNAL OF HYPERTENSION, 2003, 21 : S70 - S70